Protara Therapeutics (TARA) Earnings Date, Estimates & Call Transcripts $3.37 -0.02 (-0.59%) Closing price 04:00 PM EasternExtended Trading$3.39 +0.02 (+0.62%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Protara Therapeutics Earnings Summary Latest Q4 Earnings DateMar. 12EstimatedConsensus EPS (Mar. 12) -$0.57 Actual EPS (Mar. 12) -$0.48 Beat By $0.09 Protara Therapeutics issued Q4 2024 earnings on March 12, 2025, reporting an EPS of -$0.48, which beat analysts' consensus estimates of -$0.57 by $0.09. With a trailing EPS of -$2.40, Protara Therapeutics' earnings are expected to decrease next year, from ($3.32) to ($3.40) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Annual Report (10-K) Press Release (8-K)Powered by Get Protara Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Protara Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataTARA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Protara Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.53-$0.37-$0.45Q2 20252-$0.55-$0.44-$0.50Q3 20252-$0.57-$0.52-$0.55Q4 20252-$0.60-$0.60-$0.60 FY 2025 8 -$2.25 -$1.93 -$2.09 Q1 20261-$0.57-$0.57-$0.57Q2 20261-$0.60-$0.60-$0.60Q3 20261-$0.68-$0.68-$0.68Q4 20261-$0.77-$0.77-$0.77 Protara Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails3/12/2025Q4 2024-$0.57-$0.48+$0.09-$0.48--11/12/2024--$0.50-$0.50--$0.50--8/6/2024--$0.82-$0.45+$0.37-$0.45--5/2/2024Q1 2024-$0.99-$0.97+$0.02-$0.97--3/13/2024Q4 2023-$1.03-$0.90+$0.13-$0.90--11/3/2023Q3 2023-$1.10-$0.87+$0.23-$0.87--8/3/2023Q2 2023-$0.97-$1.00 -$0.03-$1.00-- Protara Therapeutics Earnings - Frequently Asked Questions When did Protara Therapeutics announce their last quarterly earnings? Protara Therapeutics (NASDAQ:TARA) last announced its quarterly earning data on Wednesday, March 12, 2025. Learn more on TARA's earnings history. Did Protara Therapeutics beat their earnings estimates last quarter? In the previous quarter, Protara Therapeutics (NASDAQ:TARA) reported ($0.48) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.57) by $0.09. Learn more on analysts' earnings estimate vs. TARA's actual earnings. How much profit does Protara Therapeutics generate each year? Protara Therapeutics (NASDAQ:TARA) has a recorded net income of -$40.42 million. TARA has generated -$2.40 earnings per share over the last four quarters. What is Protara Therapeutics's EPS forecast for next year? Protara Therapeutics's earnings are expected to decrease from ($3.32) per share to ($3.40) per share in the next year. More Earnings Resources from MarketBeat Related Companies STOK Earnings Results MRVI Earnings Results VERV Earnings Results GHRS Earnings Results MNMD Earnings Results SAGE Earnings Results UPB Earnings Results DNA Earnings Results RGNX Earnings Results PGEN Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Palantir Stock Drops Despite Stellar Earnings: What's Next?Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?Is Reddit Stock a Buy, Sell, or Hold After Earnings Release?Warning or Opportunity After Super Micro Computer's EarningsAmazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousRocket Lab Braces for Q1 Earnings Amid Soaring ExpectationsMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2 This page (NASDAQ:TARA) was last updated on 5/6/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredREVEALED: Elon’s Secret Master Plan “AGENDA X”REVEALED: Elon's Secret Master Plan "AGENDA X" For almost 30 years, Elon worked on his master plan in secre...Brownstone Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
